by Elana Gotkine About one in five older adults reported cost-related medication nonadherence in 2022, according to a study published online May 18 in JAMA Network Open. Stacie B. Dusetzina, Ph.D., from the Vanderbilt University School of Medicine in Nashville, Tennessee, and colleagues examined older adults’ cost-related medication nonadherence in a nationally representative survey of adults aged...
19 May 2023 By DAVID NIELD (Marko Geber/DigitalVision/Getty Images) Many of us will be familiar with feelings of sluggishness and lethargy in the afternoon, but for those with obstructive sleep apnea (OSA), the problem is more severe. Fortunately, researchers have now identified a drug that offers a good chance of helping. And no, it doesn’t come in espresso form....
Nicole DeFeudis Editor Bausch + Lomb and Novaliq secured an approval for their dry eye disease drop on Thursday, to be marketed as Miebo. The drug, also known as perfluorohexyloctane ophthalmic solution or previously NOV03, targets tear evaporation, a leading cause of dry eye disease. Bausch + Lomb CEO Brent Saunders expects the drug to...
by Ariana Baldassano, Rush University Medical Center Credit: Pixabay/CC0 Public Domain Why does the White House want to put $11.3 billion toward eliminating hepatitis C? Because as many as 75% of people who have it don’t know it. Nearly a decade after the FDA approved the first antiviral pill to cure hepatitis C, people most likely won’t know...
by Crystal Mackay, University of Western Ontario Image of a spine. Credit: Séguin Lab / University of Western Ontario After hearing firsthand from patients about how the disease impacted their lives, a team of researchers and graduate students at University of Western Ontario were inspired to investigate the symptoms associated with an understudied spine disease called...
Megan Brooks May 16, 2023 The US Food and Drug Administration (FDA) has expanded the indication for Abbott Laboratories’ spinal cord stimulation (SCS) devices to include treatment of chronic back pain in patients who have not had, or are not eligible for, back surgery, the company has announced. The new indication spans all of Abbott’s SCS devices in the US, which...
by Elana Gotkine There is a current surge in respiratory syncytial virus (RSV) infections, especially among older children, according to a research letter published online May 15 in JAMA Pediatrics. Suchitra Rao, M.B.B.S., from the University of Colorado School of Medicine and Children’s Hospital Colorado in Aurora, and colleagues compared the age distribution of children hospitalized...
Megan Brooks May 02, 2023 When it comes to relieving migraine headache, triptans, ergots, and antiemetics are the most effective classes of medications, a new real-world analysis of data on more than 3 million migraine attacks shows. Dr Chia-Chun Chiang The findings “align with results of clinical trials and recommendations from clinical treatment guidelines” and provide insights to complement clinical practice, study investigator Chia-Chun...
Marlene Busko May 12, 2023 Time-in-range (TIR) readings from a continuous glucose monitor (CGM) complemented A1c readings and provided a more complete picture of glucose control in patients with type 2 diabetes taking basal insulin, in a post-hoc analysis of the SWITCH PRO clinical trial. TIR was inversely related to A1c, with the strongest correlation following treatment intensification. However, “there was a wide scatter of...
Megan Brooks May 12, 2023 Statins have disease-modifying potential in people with non-cirrhotic chronic liver disease (CLD) by reducing the risk for progression to severe liver disease, new research shows. The Swedish population-based study found that adults with non-cirrhotic CLD who were on statin therapy had a statistically significant 40% lower risk of developing severe liver...
